Effect of Cogent db, a herbal drug, on serum and tissue lipid metabolism in experimental hyperglycaemic rats

Diabetes, Obesity and Metabolism

Volumn 5, Issue 3, 2003, Pages 156-162

  Saravanan, G ^a   Pari, L ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Alloxan diabetic rats; Blood glucose; Cogent db; Glucose 6 phosphate dehydrogenase; Lipid metabolism; Malic enzymes; Plasma insulin

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; AZARDIRACHTA INDICA EXTRACT; BIGUANIDE DERIVATIVE; COGENT DB; CURCUMA LONGA EXTRACT; EMBLICA OFFICINALIS EXTRACT; GLIBENCLAMIDE; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HERBACEOUS AGENT; INSULIN; LIPID; LIVER ENZYME; MALATE DEHYDROGENASE (DECARBOXYLATING); PLANT EXTRACT; ROTULA AQUATICA EXTRACT; SULFONYLUREA DERIVATIVE; SYZIGIUM CUMINI EXTRACT; TERMINALIA BELLERICA EXTRACT; TERMINALIA CHEBULA EXTRACT; TRIBULUS TERRESTRIS EXTRACT; TRIGONELLA FOENUM GRAECUM EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AZARDIRACHTA; BODY WEIGHT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CURCUMA LONGA; DIABETES MELLITUS; DOSE RESPONSE; DRUG ANALYSIS; DRUG EFFECT; DRUG MECHANISM; DRUG MIXTURE; ENZYME ACTIVITY; FENUGREEK; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; KIDNEY PARENCHYMA; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; LIPOGENESIS; MALE; MEDICINAL PLANT; NONHUMAN; PHYLLANTHUS; RAT; ROTULA; STATISTICAL ANALYSIS; SYZIGIUM; TERMINALIA; TRIBULUS TERRESTRIS;

EID: 0037407396     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2003.00257.x     Document Type: Article

References (48)

1. Scheen JA. Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments. Drugs 1997; 54: 355-368.
2. Standl E. Cardiovascular risk in type 2 diabetes. Diabetes Obes Metab 1999; 1: 24-36.
3. Gaster B, Hirsch IB. The effects of improved glycemic control on complications in type 2 diabetes. Arch Intern Medical 1998; 158: 134-140.
4. Pyorala K, Steiner G. Will correction of dyslipoproteinaemia reduce coronary heart disease risk in patients with non-insulin-dependent diabetes? Need for trail evidence. Ann Med 1996; 28: 357-362.
5. Rang HP, Dale MM. The Endocrine System Pharmacology. 2nd Edn. Harlaw: Longman 1991; 504-508.
6. Grovar JK, Vats V, Rathi SS. Anti-hyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. J. Ethnopharmacol 2000; 73: 461-470.
7. Pari L, Umamahaeswari J. Antihyperglycaemic activity of Musa sapientum flowers: effect on lipid peroxidation in alloxan diabetic rats. Phytother Res 2000; 14: 136-138.
8. World Health Organization. Second report of the WHO expert committee on diabetes mellitus. Technical report Series 1980; 646: 66.
9. Upadhayay UP, Pandey K. Ayurvedic approach to diabetes mellitus and its management by indigenous resources. In: Bajaj, JS, ed. Diabetes Mellitus in Developing Countries. New Delhi: Interprint 1984; 375-377.
10. Kumari KS, Devi KS. Effect of indigenous drugs on glucuronoglycan metabolism in diabetic hypertensive rabbits Ind J Exp Biol 1993; 31: 595-599.
11. Mitra SK, Gopumadhavan S, Muralidhar TS, et al.. Effect of a herbomineral preparation D-400 in streptozotocin induced diabetic rats. J Ethnopharmacol 1996; 54: 41-46.
12. Bhattacharya SK, Satyan KS, Chakrabrati A. Effect of Trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats. Ind J Exp Biol 1997; 35: 297-299.
13. Pari L, Ramakrishnan R, Venkateswaran S. Antihyperglycaemic effect of Diamed, a herbal formulation, in experimental diabetes in rats. J Pharm Pharmacol 2001; 53: 1139-1143.
14. Pari L, Saravanan G. Antidiabetic effect of Cogent db, a herbal drug in alloxan-induced diabetes mellitus. Comp Biochem Physiol Part C 2002; 131: 19-25.
15. Prince PSM, Menon VP. Hypogycaemic and other related actions of Tinospora codifolia roots in alloxan diabetic rats. J Ethnopharmacol 2000; 70: 19-25.
16. Sasaki T, Matsy S, Sonae A. Effect of acetic acid concentration on the colour reaction in the o-toluidine-boric acid method for glucose estimation. Rinsho Kagaku 1972; 1: 346-353.
17. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids form animal tissues. J Biol Chem 1957; 226: 497-509.
18. Lowry OH, Rosenbrough NJ, Farr AL, et al. Protein measurement with the Folin Phenol reagent. J Biol Chem 1951; 193: 265-275.
19. Baquer NZ, Cascades M, McLean P, et al.. Effects of thyroid deficiency on the distribution of hepatic metabolites and control pathways of carbohydrate metabolism in liver and adipose tissue of the rat. Eur J Biochem 1976; 68: 403-413.
20. Zak B, Boyle AJ, Zlatkis A. A method for the determination of cholesterol. J Clin Med 1953; 41: 486-492.
21. Rice EW. Determination of triglycerides. In: Roderick, P, MacDonald, RP, eds. Standard Method of Clinical Chemistry, New York: Academic press, 1970; 6215-6222.
22. Zilversmit DB, Davies AK. Micro method for the determination of plasma phospholipids by trichloroacetic acid precipitation. J Laboratory Clin Med 1950; 35: 155-160.
23. Falholt K, Falholt W, Lund B. An easy colorimetric method for routine determination of free fatty acids in plasma. Clin Chem Acta 1973; 46: 105-111.
24. Growenlock A. Lipids and lipoproteins. In: Varley's Practical Clinical Biochemistry. 6th Edn. Florida: CRC Press, Boca Raton, 1988; 453-476.
25. Friedward WT, Levy RI, Fradrickson DS. Estimation of concentration of low-density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. Clin Chem 1972; 19: 449-452.
26. 3-adrenergic agonist on lipid metabolism in alloxan diabetic rats. J Pharm Pharmacol 2000; 52: 851-856.
27. Seifter S, England S. Energy metabolism. In: Arias, I, Popper, H, Schacter, D, eds. The Liver: Biology and Pathobiology, New York: Raven press, 1982; 219-249.
28. Arky RA. Clinical correlates of metabolic derangements of diabetes mellitus. In: Kozak GP, ed. Complications of Diabetes Mellitus. Philadelphia, PA: WB Saunders, 1982; 16-20.
29. West KM. Hyperglycemia as a cause of long-term complications. In Keen H, Jarret J, eds. Complications of Diabetes, 2nd Edn. London: Edward Arnold, 1982; 3-18.
30. Venkateswaran S, Pari L. Effect of Coccinia indica on Blood glucose, Insulin and Hepatic key enzymes in experimental diabetes. Pharm Biol 2002; 40: 165-172.
31. Gupta D, Raju J, Prakash RJ, et al. Change in the lipid profile, lipogenic and selected enzymes in the livers of experimental diabetic rats: effect of insulin and vanadate. Diab Res Clin Prac 1999; 46: 1-7.
32. Malmstrom R, Packard CJ, Caslake M. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 1997; 40: 454-462.
33. Griffin BA, Freeman DJ, Tait GW. Role of plasma triglyceride in the regulation of plasma low-density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994; 106: 241-253.
34. Eisenberg S. Preferential enrichment of large sized very low-density lipoprotein populations with transferred cholesterylesters. J Lipid Res 1985; 26: 487-494.
35. McEneny J et al. Very low density lipoprotein subfractions in Type II diabetes mellitus; alterations in composition and susceptibility to oxidation. Diabetologia 2000; 43: 485-493.
36. Prince PSM, Menon VP, Gunasekaran G. Hypolipidaemic action of Tinospora cordifolia root in alloxan diabetic rats. J Ethnopharmacol 1999; 64: 53-57.
37. Puspharaj P, Tan CH, Tan BKH. Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. J Ethnopharmacol 2000; 72: 69-76.
38. Rhoads GG, Gulbrandsne CL, Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. New Engl J Med 1976; 294: 293-298.
39. Viberti GC, Mackintosh D, Bilous RW, et al.. Proteinuria in diabetes mellitus role of spontaneous and experimental variations of glycemia. Kidney Int 1982; 21: 714-720.
40. Agrawal B, Berger A, Wolf K, et al. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertension 1996; 14: 223-228.
41. Al-Shamaony LAI, -Khazraji SM, Twaiji HA. Hypoglycaemic effect of Artemisia herba Alba II. Effect of a valuble extract on some blood parameters in diabetic animals. J Ethnopharmacol 1994; 43: 167-171.
42. Laakso M. Epidemiology of diabetic dyslipidemia. Diab Rev 1995; 3: 408-422.
43. Taskinen MR, Beltz WF, Harper I. Effects of NIDDM on very-low-density lipoprotein, triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy. Diabetes 1986; 35: 1268-1277.
44. Khosla P, Gupta DD, Nagpal RK. Effect of Trigonella foenum graecum (Fenugreek) on blood glucose, serum lipids in normal and diabetic rats. Ind J Pharmacol 1995; 39: 173-174.
45. Godkar PB, Narayanan P, Bhide SV. Hypocholesterolemic effect of Turmeric extract on Swiss mice. Ind J Pharmacol 1996; 28: 171-174.
46. Bopanna KN, Kannan J, Sushma G, et al. Antidiabetic and antihyperlipaemic effect of neem seed kernel powder on alloxan diabetic rabbits. Ind J Pharmacol 1997; 29: 162-167.
47. Prince PSM, Menon VP. Hypolipidaemic Effect of Syzigium cumini (Jamun) seeds in alloxan diabetic rats. Medical Sci Res 1997; 25: 819-821.
48. Larner J. Insulin and oral hypoglycaemic drugs, glucagon. In: Gilman, AG, Goodman, LS, Rall, TW, Murad, F, eds. The Pharmacological Basis of Therapeutics, 7th edn. New York: MacMillan 1985; 1490-1516.